The Manufacturers Life Insurance Company increased its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 34.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,996 shares of the company’s stock after buying an additional 5,859 shares during the period. The Manufacturers Life Insurance Company owned 0.05% of Avanos Medical worth $553,000 at the end of the most recent reporting period.
Several other institutional investors also recently added to or reduced their stakes in AVNS. KBC Group NV raised its stake in shares of Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after buying an additional 1,095 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in Avanos Medical in the second quarter worth about $70,000. XTX Topco Ltd acquired a new position in Avanos Medical in the second quarter worth about $202,000. Intech Investment Management LLC bought a new position in Avanos Medical during the third quarter worth about $207,000. Finally, Magnetar Financial LLC acquired a new stake in Avanos Medical during the second quarter valued at approximately $248,000. 95.17% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.
Avanos Medical Stock Down 2.5 %
Shares of NYSE AVNS opened at $17.97 on Friday. Avanos Medical, Inc. has a 52-week low of $17.39 and a 52-week high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The business has a fifty day moving average of $20.27 and a two-hundred day moving average of $21.43. The stock has a market cap of $825.90 million, a PE ratio of 52.85 and a beta of 0.95.
Avanos Medical Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- 3 Monster Growth Stocks to Buy Now
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Special Dividend?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.